Research Ethics at MMSx Authority

Last updated: November 25, 2025

MMSx Authority Institute for Movement Mechanics & Biomechanics Research Inc. is committed to conducting all research activities with the highest standards of scientific integrity, technical rigor, and ethical conduct. As a nonprofit research institute specializing in biomechanics, movement science, and fitness innovation, we adhere strictly to Good Clinical Practice (GCP) guidelines, international ethical standards, and regulatory requirements to ensure participant safety, data integrity, and scientific validity in studies like our Balanced Progressive Intensity Training (BPIT) clinical trials.

1. Ethical Framework and GCP Compliance

All MMSx Authority research follows ICH-GCP E6(R2) guidelines, ensuring ethical treatment, scientific quality, and regulatory compliance. Our studies, such as BPIT multi-site evaluations, prioritize participant welfare while advancing evidence-based movement science.

• Protocol development emphasizes risk-benefit assessment and scientific soundness.
• Independent ethics committees review all protocols before initiation.
• Technical standards integrate advanced biomechanics tools for precise data collection.

2. Institutional Review Board (IRB) and Ethics Committee Oversight

The MMSx Authority Ethics Committee (MACREB) provides independent oversight for all studies, in line with OHRP-HHS USA and ICMR India standards. For BPIT-GFFI-2024-001 and similar protocols, we ensure:

• Full IRB approval before participant recruitment.
• Ongoing monitoring and annual reviews.
• Adverse event reporting within GCP timelines.

3. Informed Consent Process

Participant informed consent is foundational to our ethical practice. Forms, like those for BPIT multi-site studies, are clear, comprehensive, and GCP-compliant:

• Voluntary participation with no coercion.
• Full disclosure of procedures, risks (e.g., temporary soreness), and benefits.
• Right to withdraw at any time without prejudice.
• Special provisions for vulnerable populations when applicable.

4. Data Integrity and Scientific Rigor

As a science-based institute, we maintain technical excellence through:

• Pre-specified statistical analysis plans (e.g., BPIT outcomes like MES change, ROM, HRV-RMSSD).
• Secure data management with anonymization and HIPAA/GDPR compliance.
• Audit-ready documentation and version control (e.g., protocol v3.1 dated Nov 25, 2025).
• Peer review of all publications and DOIs (e.g., Zenodo 10.5281/zenodo.17594478).

5. Conflict of Interest and Transparency

As a nonprofit, we disclose all potential conflicts:

• No commercial funding influences research design or outcomes.
• Collaborators (e.g., GFFI, BodyGNTX) sign expert consent forms declaring impartiality.
• All studies registered on ClinicalTrials.gov (e.g., NCT07220200 for MOVE protocol).

6. Participant Protection and Safety

Safety is paramount in our technical, science-based approach:

• Risk assessments in protocols minimize harm (e.g., BPIT's progressive intensity monitoring).
• Adverse event protocols with immediate reporting to ethics committees.
• Inclusive practices ensuring diversity in study populations.

7. Complaints and Oversight

We maintain open channels for ethical concerns:

• Anonymous reporting to MACREB ethics committee.
• Independent audits of all GCP elements.
• Annual ethics training for all researchers and collaborators.